Klarsen specializes in data marketing for customer winning and engagement. Thanks to its qualified data and proprietary technologies, it allows its customers to increase their marketing performance and net sales. Klarsen disposes of proprietary assets and qualified and reactive databases, in its network of partners and on its own.

Employees

Sector

IT Services & Consulting

More about the company

Quotes

Date	Price	Change
03/07/26	€0.3800	0.00%
02/07/26	€0.3800	0.00%
01/07/26	€0.3800	0.00%
30/06/26	€0.3800	0.00%
29/06/26	€0.3800	0.00%

Real-time Euronext Paris

More quotes

Income Statement and Estimates

More financial data

Market Closed - Euronext Paris Other stock markets 16:55:00 03/07/2026 BST			5-day change	1st Jan Change
0.3800 ^EUR	0.00%		0.00%	-56.22%

11-03	Klarsen Reports Earnings Results for the Half Year Ended June 30, 2025	CI
29/04/25	Klarsen Reports Earnings Results for the Full Year Ended December 31, 2024	CI

Market Cap	2.88M 3.29M 2.64M 2.46M 4.67M 313M 4.74M 31.73M 12.34M 154M 12.35M 12.08M 531M	P/E 2023	3.28x	P/E 2024	-86x
Enterprise Value	3.96M 4.53M 3.64M 3.39M 6.43M 431M 6.53M 43.66M 16.97M 212M 16.99M 16.63M 730M	EV / Sales 2023	1.67x	EV / Sales 2024	0.82x
Free-Float	98.11%	Yield 2023 *	-	Yield 2024	-

11-03	Klarsen Reports Earnings Results for the Half Year Ended June 30, 2025	CI
29/04/25	Klarsen Reports Earnings Results for the Full Year Ended December 31, 2024	CI
15/10/24	Klarsen Reports Earnings Results for the Half Year Ended June 30, 2024	CI
29/04/24	Klarsen Reports Earnings Results for the Full Year Ended December 31, 2023	CI
15/03/24	Acticor Biotech Raises EUR8 Million to Fund Emergency Stroke Treatment Development	MT
07/11/23	Acticor Biotech’s Phase 2/3 Trial for Stroke Drug Combo on Track for 2024 Results	MT
27/10/23	Klarsen Reports Earnings Results for the Half Year Ended June 30, 2023	CI
27/04/23	Klarsen Reports Earnings Results for the Full Year Ended December 31, 2022	CI
09/03/23	Acticor Biotech Secures Funding Until November After EUR12 Million Equity Raise; Stock Sinks 17%	MT
23/12/22	Acticor Biotech Seeks To Meet With US FDA Over Phase 2/3 Study Of Stroke Drug	MT
14/12/22	Twitter to shut down newsletter product Revue next year	RE
06/12/22	Acticor Biotech Wins EU Health Agency Nod For Phase 2/3 Stroke Study Design	MT
05/10/22	Klarsen Reports Earnings Results for the Half Year Ended June 30, 2022	CI

03-03	Klarsen : ALKLA information relative au nombre total de droits de vote et d'actions composant le capital	PU
02-25	Klarsen : ALKLA-Information relative au nombre de droits de vote et actions composant le capital	PU
12-10	Klarsen : ALKLA-Attribution gratuite de BSA	PU
12-09	Klarsen : ALKLA-ACTIVITE 3T2025	PU
11-27	Klarsen : ALKLA-Résultat augmentation de capital	PU

Klarsen Share Price

Stocks

ALKLA

FR0011038348

IT Services & Consulting

Valuation: Klarsen

Chart: Klarsen

Latest news : Klarsen

Press Releases: Klarsen

News in other languages: Klarsen

Quotes and Performance

Course Extremes

Managers and Directors: Klarsen

Latest insider transactions

Other IT Services & Consulting

Financials

Company Profile

Quotes

Income Statement and Estimates

07-01	Bourse : Schneider se renforce dans l'IA, Air Liquide investit pour SK Hynix, Nike déçoit
07-01	La Bourse s'habitue à tout
06-30	Klarsen : ALKLA – Point d’information sur la publication des comptes annuels 2025 et la suspension de cotation – 30 Juin 2026
06-09	Klarsen : ALKLA – Report des résultats trimestriels et date de publication des comptes annuels – 9 Juin 2026
06-01	Klarsen : Information réglementée – 2026

1 month	-24.60%
3 months	-55.81%
6 months	-56.72%
Current year	-56.22%

1 week	0.38	0.38
1 month	0.38	0.53
Current year	0.22	1.18
1 year	0.22	1.18
3 years	0.22	4.03
5 years	0.22	4.03
10 years	0.11	5.4

Manager	Title	Age	Since
Brice Gazeau CEO	Chief Executive Officer	-	-
Patrice Coffe DFI	Director of Finance/CFO	57	30/06/2008
Jean-Pierre Domingo CTO	Chief Tech/Sci/R&D Officer	-	31/12/2012

Director	Title	Age	Since
Patrice Coffe BRD	Director/Board Member	57	13/06/2010
Gérard Parrou BRD	Director/Board Member	74	26/06/2014
Frédéric Bartoli BRD	Director/Board Member	-	22/03/2011

Date	Insider	Type	Main position	Quantity	% Market Cap.
14/03/22	Parrou Julien	Buy		2,617	0.0790%
27/02/22	Julien Parrou-Duboscq	Buy	Chief Executive Officer	3,011	0.0909%
27/02/22	Julien Parrou-Duboscq	Buy	Chief Executive Officer	11,500	0.3471%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
KLARSEN	0.00%	0.00%	-65.45%	-88.31%	1.44M
IBM	+1.14%	+6.59%	-0.84%	+116.59%	272B
SNOWFLAKE INC.	-0.40%	+4.49%	+17.45%	+46.99%	90.17B
ACCENTURE PLC	+4.74%	+6.49%	-54.93%	-55.83%	84.05B
TATA CONSULTANCY SERVICES LTD.	+1.23%	-0.06%	-38.78%	-36.73%	79.55B
RELX PLC	-0.81%	-1.23%	-40.14%	-9.92%	54.92B
INFOSYS LIMITED	+0.61%	+0.58%	-36.17%	-22.15%	44.51B
FUJITSU LIMITED	-0.54%	+3.97%	-3.73%	+81.25%	35.78B
NEC CORPORATION	-0.76%	+9.83%	+5.87%	+196.57%	34.28B
HCL TECHNOLOGIES LIMITED	+5.65%	+3.48%	-34.01%	-4.33%	32.37B
Average	+1.09%	+5.24%	-25.07%	+22.41%	72.77B
Weighted average by Cap.	+1.22%	+8.14%	-15.40%	+49.91%

	2023	2024
Net sales	5.03M 5.75M 4.62M 4.31M 8.17M 547M 8.29M 55.45M 21.56M 269M 21.58M 21.12M 927M	6.31M 7.22M 5.8M 5.41M 10.25M 687M 10.41M 69.63M 27.07M 338M 27.1M 26.52M 1.16B
Net income	2.75M 3.15M 2.53M 2.36M 4.47M 300M 4.54M 30.35M 11.8M 147M 11.81M 11.56M 507M	-47.76K -54.64K -43.9K -40.92K -77.61K -5.2M -78.78K -527K -205K -2.56M -205K -201K -8.81M
Net Debt	-634K -726K -583K -543K -1.03M -69.1M -1.05M -7M -2.72M -33.97M -2.72M -2.67M -117M	1.08M 1.24M 993K 926K 1.76M 118M 1.78M 11.92M 4.64M 57.86M 4.64M 4.54M 199M